Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life.

Hanneke PoortJamie M JacobsWilliam F PirlJennifer S TemelJoseph A Greer

Published in: Palliative & supportive care (2021)

One in four patients on oral treatment for cancer experienced clinically relevant fatigue that is associated with greater anxiety and depressive symptoms and worse QOL.

Keyphrases

depressive symptoms
end stage renal disease
sleep quality
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
squamous cell carcinoma
squamous cell
drug delivery
patient reported outcomes
social support
rectal cancer
lymph node metastasis